Risk-Return Analysis of the Biopharmaceutical Industry as Compared to Other Industries

Background: Profits in the biopharmaceutical industry have been scrutinized in social debate. However, drawing conclusions based on industry profitability only is inappropriate as such an analysis does not account for risks faced by investors. This study aims to measure risks and returns in the biop...

Full description

Bibliographic Details
Main Authors: Cedric Popa, Karel Holvoet, Tessa Van Montfort, Floris Groeneveld, Steven Simoens
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01108/full